Table 3(b).
GO IDs
|
GO term
|
Genes
|
P-value
|
---|---|---|---|
Biological processes | |||
GO:0007155 | Cell adhesion | ADAM12, CDH15, COL1A1, PTPRK, PTPRF, DSC2, ATP1B2, CD96, DSC2, COL1A1, MCAM | 0.00093 |
GO:0050900 | Leukocyte migration | ANGPTL1, COL1A1, ATP1B2, PECAM1, PTPN6, DOK2 | 0.0013 |
GO:0030282 | Bone mineralization | CLEC3B, WNT11, FGFR3, TUFT1 | 0.0014 |
GO:0008277 | Regulation of G-protein coupled receptor protein signaling pathway |
GNG4, RGS18, RGS9,
RAMP1 |
0.0022 |
GO:2000147 | Positive regulation of cell motility | CCR7, CSF1R, TWIST1 | 0.0037 |
GO:0006909 | Phagocytosis | CEBPE, CD93, ELANE, PECAM1 | 0.0039 |
GO:0035335 | Peptidyl-tyrosine dephosphorylation | PTPN6, PTPN7, PTPRK,PTPRF, DUSP6 | 0.0042 |
GO:0034394 | Protein localization to cell surface | WNT11, ANGPTL1, PTPRK | 0.0051 |
GO:0043066 | Negative regulation of apoptotic process | GLI3, WNT11, ANGPTL1, ANGPTL4, CSF1R, DHRS2, TWIST1, MYC | 0.0068 |
GO:0006468 | Protein phosphorylation | FES, MOK, WNT11, CDK14, LMTK3, TRIB3, RPS6KA4 | 0.024 |
GO:0060548 | Negative regulation of cell death | WNT11, CST3, MYC | 0.030 |
GO:0030097 | Hematopoiesis | ANGPTL1, CSF1R, GFI1 | 0.034 |
GO:0008285 | Negative regulation of cell proliferation | PTPN6, PTPRK, GL13, CSF1R, DHRS2, DLG3CBFA2T3 | 0.048 |
GO:0042493 | Response to drug | FOS, COL1A1, CST3, HDAC5, MYC | 0.062 |
GO:0001525 | Angiogenesis | ANGPTL1, ANGPTL4, PECAM1, RAMP1, MCAM | 0.096 |
GO:0007017 | Microtubule-based process | TUBB2A, TUBB3 | 0.10 |
Molecular Functions | |||
GO:0004725 | Protein tyrosine phosphatase activity | PTPN6, PTPN7, PTPRF, PTPRK, DUSP6 | 0.0038 |
GO:0005001 | Transmembrane receptor protein tyrosine phosphatase activity | PTPN6, PTPRF, PTPRK | 0.0051 |
GO:0030246 | Carbohydrate binding | CLEC3B, CLEC4B, PRG2, LGALS12 | 0.036 |
GO:0004672 | Protein kinase activity | MOK, TRIB3, CDK14, LMTK3, STK33, MAP3K9 | 0.078 |
GO:0008201 | Heparin binding | CLEC3B, ELANE, PTPRF, PRG2 | 0.081 |
GO:0004674 | protein serine/threonine kinase activity | MOK, SBK1, LMTK3, MAP3K9, RPS6KA4, STK33 | 0.091 |
GO:0008013 | Beta-catenin binding | GLI3, DACT3, PTPRK | 0.095 |
GO:0003700 | Transcription factor binding | FOS, PBX2, HDAC5, TWIST1, MYC | 0.100 |
Pathways | |||
Transcriptional misregulation in cancer | CEBPE, LMO2, CSF1R, CDK14, MYC, ELANE | 0.0014 | |
MAPK signaling pathway | FOS, PTPN7, MYC, RPS6KA4 | 0.010 | |
PI3K-Akt signaling pathway | DDIT4, GNG4, ANGPTL1, COL1A1, CSF1R, FGFR3, MYC | 0.041 | |
Pathway in cancer | FOS, GNG4, GLI3, WNT11, CSF1R, FGFR3, MYC | 0.069 | |
Hippo signaling pathway | WWCI, WNT11, MYC, DLG3 | 0.10 | |
Proteoglycans in cancer | WNT11, PTPN6, TWIST1, MYC | 0.18 | |
Ras signaling | GNG4, ANGPTL4, CSF1R, FGFR3 | 0.23 | |
Phagosome | TUBB2A, TUBB3 | 0.10 |
(DAVID software analysis, EASE score, p< 0.1)